ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor that regulates cell growth and differentiation, with many breast cancer patients (20–30%) presenting an amplified expression of the protein [21].